Xi Han Wu
Chief Executive Officer at Zhejiang Sunovo Pharmaceutical Co., Ltd.
Net worth: 3 M $ as of 29/04/2024
Profile
Xi Han Wu is the founder of PharmaBlock Sciences (Nanjing), Inc., which was founded in 2006.
Dr. Wu held the titles of Secretary, Chief Technology Officer, and Deputy GM at PharmaBlock Sciences (Nanjing), Inc. Currently, Dr. Wu is the Chairman and General Manager at Zhejiang Sunovo Pharmaceutical Co., Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/06/2023 | 752,953 ( 0.45% ) | 3 M $ | 29/04/2024 |
Xi Han Wu active positions
| Companies | Position | Start |
|---|---|---|
Zhejiang Sunovo Pharmaceutical Co., Ltd.
 Zhejiang Sunovo Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Porton Pharmaceutical Co., Ltd. engages in the provision of technical services for innovative medicines, research and development of chemical raw materials, and production and sale of pharmaceutical intermediates and chemical products. The company was founded on November 18, 2009 and is headquartered in China. | Chief Executive Officer | - |
Former positions of Xi Han Wu
| Companies | Position | End |
|---|---|---|
| PHARMABLOCK SCIENCES (NANJING), INC. | Founder | 13/11/2019 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHARMABLOCK SCIENCES (NANJING), INC. | Commercial Services |
| Private companies | 1 |
|---|---|
Zhejiang Sunovo Pharmaceutical Co., Ltd.
Zhejiang Sunovo Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Porton Pharmaceutical Co., Ltd. engages in the provision of technical services for innovative medicines, research and development of chemical raw materials, and production and sale of pharmaceutical intermediates and chemical products. The company was founded on November 18, 2009 and is headquartered in China. | Health Technology |
- Stock Market
- Insiders
- Xi Han Wu
